NYMBL SCIENCE, INC.

Profile

Company Names

NYMBL SCIENCE, INC.

Addresses

2000 S COLORADO BLVD, TOWER 2, SUITE 320, DENVER, CO 80222

ANNEX, 2000 S COLORADO BLVD #240, DENVER, CO 80222

3513BRIGHTON BLVD., SUITE 478, DENVER, CO 80216

3513 BRIGHTON BLVD., SUITE 478, DENVER, CO 80216

Phone Numbers

650-233-4548

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, OTHER TECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$15,781,533.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-08-29 
$984,057.00 
$2,351,745.00 
$1,367,688.00 
Debt 
3
2022-10-17 
$8,752,476.00 
$13,000,000.00 
$4,247,524.00 
Equity 
2
2020-09-24 
$3,720,000.00 
$3,960,000.00 
$240,000.00 
Equity 
1
2019-06-27 
$2,325,000.00 
$2,675,000.00 
$350,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JAMES 
 
COOK 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
BOTTLENOTES INC   |  ELYRIA FOUNDRY HOLDINGS LLC   |  PINNACLE PROPERTIES-EVERETT, LLC   |  KISSNER GROUP HOLDINGS LP   |  LAKELAND HOLDINGS, LLC   |  JUMIO HOLDINGS, INC.   |  NYMBL SCIENCE, INC.   |  EVERGREEN THERAGNOSTICS INC.   |  FREESPACE ROBOTICS INC.   |  SAPIENCE AI CORP
DAVID 
 
EICHLER 
DIRECTOR
ADVANCED MOLECULAR IMAGING, LLC   |  TRAINER RX, INC.   |  NYMBL SCIENCE, INC.   |  ARISTAMD, INC.
DR. JEAN-PIERRE 
 
FARCY 
PROMOTER
NYMBL SCIENCE, INC.
CAROL 
OWENS 
JONES 
PROMOTER
NYMBL SCIENCE, INC.
EDWARD 
 
LIKOVICH 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
GOODLUX TECHNOLOGY, LLC   |  NYMBL SCIENCE, INC.
PHILIP 
 
LINVILLE 
DIRECTOR
NYMBL SCIENCE, INC.
MEGHAN 
 
OLIVER 
DIRECTOR
NYMBL SCIENCE, INC.
CAROLINE 
 
OWEN-JONES 
PROMOTER
NYMBL SCIENCE, INC.
CHRIS 
 
SAXMAN 
DIRECTOR
CIRRUSMD INC.   |  ROCKIES VENTURE FUND I, LP   |  NYMBL SCIENCE, INC.
ROHIT 
 
SETH 
DIRECTOR
SIPERA SYSTEMS INC   |  AIRWALK COMMUNICATIONS INC   |  AVESO INC   |  ECHO 360 HOLDINGS, INC.   |  NYMBL SCIENCE, INC.
THOMAS 
 
VIRDEN 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
NYMBL SCIENCE, INC.
BEN 
 
WIRE 
DIRECTOR
NYMBL SCIENCE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-09-12
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2025-08-29 
2022-12-01
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-17 
2020-10-07
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-24 
2019-08-01
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-27 
2019-07-12
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#